M306-1925 Screening compound: N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-3-{1-[(4-methylphenyl)sulfonyl]-4-piperidyl}propanamide

M306-1925 Screening compound: N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-3-{1-[(4-methylphenyl)sulfonyl]-4-piperidyl}propanamide
M306-1925 Screening compound: N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-3-{1-[(4-methylphenyl)sulfonyl]-4-piperidyl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M306-1925
N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-3-{1-[(4-methylphenyl)sulfonyl]-4-piperidyl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M306-1925

Molecular Formula

C19H28N2O5S2 (C19 H28 N2 O5 S2)

Compound Name

N~1~-(1,1-dioxotetrahydro-1H-1lambda~6~-thiophen-3-yl)-3-{1-[(4-methylphenyl)sulfonyl]-4-piperidyl}propanamide

IUPAC name

N-(11-dioxo-1lambda6-thiolan-3-yl)-3-[1-(4-methylbenzenesulfonyl)piperidin-4-yl]propanamide

SMILES

Cc(cc1)ccc1S(N1CCC(CCC(NC(CC2)CS2(=O)=O)=O)CC1)(=O)=O

InChI

InChI=1S/C19H28N2O5S2/c1-15-2-5-18(6-3-15)28(25,26)21-11-8-16(9-12-21)4-7-19(22)20-17-10-13-27(23,24)14-17/h2-3,5-6,16-17H,4,7-14H2,1H3,(H,20,22)/t17-/m1/s1

InChI Key

HMQFHDBVNVFDHZ-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD29007919

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

428.57

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.674

Distribution Coefficient, logD

1.674

Water Solubility, LogSw

-2.54

Polar Surface Area

84.312

Acid Dissociation Constant (pKa)

15.74

Base Dissociation Constant (pKb)

-3.06

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

63.20

M306-1925 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Arginase Targeted Library (2009 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Male
  • Cardiovascular
  • Cancer
  • Hemic and lymphatic
Targets:
  • Others
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with M306-1925 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M306-1925?
Check Price and Availability of M306-1925, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M306-1925 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M306-1925
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M306-1925
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M306-1925 available by request